IDEAYA Biosciences, Inc. (NASDAQ:IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 42nd Annual J.P. Morgan Healthcare
Chinese social media and gaming giant Tencent Holdings ADR (OTC: TCEHY) reported slower-than-expected revenue growth in the second quarter, affected by a sluggish economy and competition in the